Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
Clinical trial NCT07163702 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07163702
- Sponsor
- Dongzhimen Hospital, Beijing
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-09-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.